YD Bio Ltd. Ordinary Shares YDES 深 滬
等待開盤 10-23 09:30:00 美东时间
17.51
-1.020
-5.50%
華盛通- 最 高18.66
- 今 開18.4019
- 成交量 1.98万股
- 最 低 17.51
- 昨 收 18.53
- 總市值 12.27亿
- 52周最高 25.00
- 市盈率 靜 --
- 換手率 0.03%
- 52周最低 7.20
- 委 比 60.00%
- 總股本 7009.54万
- 歷史最高 25.00
- 量 比 0.39
- 振 幅 6.21%
- 歷史最低 7.20
- 每 手 1
- 風險率
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多YD Bio Ltd. Rings Nasdaq Opening Bell to Celebrate Listing under Ticker YDES
YD Bio Limited rang the Nasdaq Opening Bell to celebrate its public listing, marking a milestone in its journey as a biotechnology company. The listing strengthens its capital base, enhances its global visibility, and accelerates the commercialization of its innovative diagnostic and regenerative medicine platforms. YD Bio, founded in 2013, has evolved from a clinical trial drug supplier to a diversified biotech innovator, leveraging strategic pa...
10-20 14:20
YD Bio Announces CAP Accreditation Of EG Biomed's CLIA-Certified Laboratory, Advancing U.S. Clinical Testing Capabilities
YD Bio Limited ("YD Bio" or the "Company") (NASDAQ:YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced that its business partner, EG
10-10 20:39
YD Bio Business Partner EG Biomed Achieves CAP Accreditation, Advancing U.S. Clinical Testing Capabilities
YD Bio's partner, EG Biomed, has achieved CAP accreditation for its CLIA-certified laboratory, enhancing its ability to deliver advanced diagnostic tests in the U.S. This milestone strengthens YD Bio's commitment to innovation in cancer detection and ophthalmology. EG Biomed's Chief R&D Officer also presented new findings on a novel biomarker for pancreatic cancer at the AACR conference.
10-10 12:37
YD Bio Limited Reports Unaudited Half Year 2025 Financial Results
YD Bio Limited announced its unaudited financial results for the six months ended June 30, 2025. The company secured $13.2 million to support YD Biopharma's operations following its merger with Breeze Holdings. Despite a 9% net revenue decline to $204,007, YD Biopharma continued investing in R&D and advanced two licensed patents to expand capacity. The top five products accounted for 56% of total revenue, with Keytruda injection being the top ear...
09-30 21:25
美股周涨跌榜 | 股价狂飙近300%！uniQure在研创新药获突破进展；特朗普政府寻求入股Lithium
股价周内狂飙近300%！uniQure在研创新药获重大进展；特朗普政府"盯上"锂矿巨头股权，Lithium Americas周内大涨95%>>
09-28 10:10
Freeport-McMoRan, Harmony Biosciences, Cohu, And Other Big Stocks Moving Lower On Wednesday
U.S. stocks were lower, with the Dow Jones index falling more than 150 points o...
09-25 02:18
美股周涨跌榜 | 核电股Oklo周涨超63%，有消息称特朗普政府正全力推进大型电力项目建设；RGTI周涨近50%
核电股Oklo周涨超63%，有消息称特朗普政府正全力推进大型电力项目建设；RGTI周涨近50%，与美国空军研究实验室合作推进超导昆腾网络技术>>
09-20 10:40
美股周涨跌榜 | 好莱坞或迎巨震！华纳兄弟探索频道周涨超55%；新思科技绩后暴跌28.9%
好莱坞或迎巨震！华纳兄弟探索频道周涨超55%，传Paramount Skydance拟收购公司；新思科技绩后暴跌28.9%>>
09-13 11:42
Why Oxford Industries Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Shares of Oxford Industries, Inc. (NYSE:OXM) rose sharply in pre-market trading...
09-11 21:01
美股牛股 | 绩优股狂飙！梅西百货大涨超20%，REV Group涨超12%；房地美ADR涨超16%
绩优股狂飙！梅西百货大涨超20%，REV Group涨超12%；房地美ADR涨超16%，美参议院议员敦促特朗普政府暂缓出售公司股份>>
09-04 17:12
